GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Harpoon Therapeutics Inc (FRA:5HTA) » Definitions » Policy Acquisition Expense

Harpoon Therapeutics (FRA:5HTA) Policy Acquisition Expense


View and export this data going back to 2019. Start your Free Trial

What is Harpoon Therapeutics Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Harpoon Therapeutics (FRA:5HTA) Business Description

Traded in Other Exchanges
Address
131 Oyster Point Boulevard, Suite 300, South San Francisco, CA, USA, 94080
Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. It is engaged in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. The company's pipeline products include HPN424, HPN536, HPN217, and others.